{"id":"W1595829166","doi":"10.1111/j.1365-2036.2010.04568.x","title":"Randomised clinical trial: improvement in health outcomes with certolizumab pegol in patients with active Crohn’s disease with prior loss of response to infliximab","year":2011,"lang":"en","type":"article","venue":"Alimentary Pharmacology & Therapeutics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"UCB Pharma","keywords":"Certolizumab pegol; Medicine; Infliximab; Crohn's disease; Internal medicine; Physical therapy; Work productivity; Disease; Productivity","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003370262,0.001753081,0.004519005,0.0005153355,0.0006450102,0.001554479,0.001308365,0.003967462,0.01607617],"category_scores_gemma":[0.00486871,0.0008209958,0.002729524,0.0006176134,0.001732132,0.001326366,0.0008264399,0.00362304,0.001899843],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001080434,"about_ca_system_score_gemma":0.001658522,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00172202,"about_ca_topic_score_gemma":0.002818197,"domain_scores_codex":[0.9977447,0.001514327,0.0001444575,0.0002598324,0.0001222657,0.0002143614],"domain_scores_gemma":[0.9975383,0.0008647385,0.0006056526,0.0002132862,0.0002159984,0.0005620538],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9933633,0.001162191,0.0002499273,0.0006011991,0.0004009684,0.00003395578,0.0000192945,0.00008830942,0.0005151578,0.00006089966,0.000532118,0.00297274],"study_design_scores_gemma":[0.9898664,0.008977076,0.0005313164,0.00002840572,0.0001072914,0.00001397679,0.000005448985,0.00007164801,0.0000400079,0.00004360363,0.0003107191,0.000004180999],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9154649,0.01681348,0.002222832,0.005289468,0.006658077,0.03628325,0.007102948,0.0003927365,0.00977242],"genre_scores_gemma":[0.9292362,0.005707734,0.003969359,0.004763711,0.002515158,0.03514906,0.005548954,0.0000604452,0.01304942],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01607617,"threshold_uncertainty_score":0.0537802,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02683136686892231,"score_gpt":0.3329184131343723,"score_spread":0.30608704626545,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}